In Practice

Implications of the 2015 World Health Organization isoniazid preventive therapy recommendations on tuberculosis prevention efforts in Namibia

Stella Anne Oloo


The World Health Organization recently released guidelines recommending 36-month use of isoniazid preventive therapy in adults and adolescents living with HIV in resource-limited settings. Namibia continues to grapple with one of the highest incidences of tuberculosis (TB) worldwide. Implementation of these guidelines requires considerations of TB epidemiology, health infrastructure, programmatic priorities and patient adherence. This article explores the challenges Namibia currently faces in its fight against TB and the implications of the new guidelines on Namibian TB prevention efforts.

Author's affiliations

Stella Anne Oloo, Department of Internal Medicine, School of Medicine, University of Namibia, Windhoek, Namibia

Full Text

PDF (63KB)


Tuberculosis; Prevention; IPT; Isoniazid preventive therapy

Cite this article

South African Medical Journal 2016;106(8):775-776. DOI:10.7196/SAMJ.2016.v106i8.10787

Article History

Date submitted: 2016-03-15
Date published: 2016-07-01

Article Views

Abstract views: 2661
Full text views: 873

Comments on this article

*Read our policy for posting comments here